Clinical Trial Update: A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and clinical activity of an immunotherapy plus chemotherapy combination in metastatic melanoma; the trial was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2017-03-30